Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dabigatran etexilate 150mg capsules
0208020X0AAACAC
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | 43,578 |
|
Dabigatran etexilate 110mg capsules
0208020X0AAABAB
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | 40,932 |
|
Dabigatran etexilate 75mg capsules
0208020X0AAAAAA
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | 485 |
|
Dabigatran etexilate 110mg granules sachets sugar free
0208020X0AAAHAH
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | 5 |
|
Dabigatran etexilate 150mg granules sachets sugar free
0208020X0AAAIAI
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | 2 |
|
Dabigatran etexilate 20mg granules sachets sugar free
0208020X0AAADAD
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | No data available |
|
Dabigatran etexilate 30mg granules sachets sugar free
0208020X0AAAEAE
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | No data available |
|
Dabigatran etexilate 40mg granules sachets sugar free
0208020X0AAAFAF
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | No data available |
|
Dabigatran etexilate 50mg granules sachets sugar free
0208020X0AAAGAG
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.